Attached files
file | filename |
---|---|
EXCEL - IDEA: XBRL DOCUMENT - THERALINK TECHNOLOGIES, INC. | Financial_Report.xls |
10-Q - FORM 10-Q - THERALINK TECHNOLOGIES, INC. | form10q.htm |
EX-31.1 - CERTIFICATION - THERALINK TECHNOLOGIES, INC. | exhibit31-1.htm |
EX-32.2 - CERTIFICATION - THERALINK TECHNOLOGIES, INC. | exhibit32-2.htm |
EX-10.38 - AMENDMENT TO STOCK OPTION AGREEMENT - THERALINK TECHNOLOGIES, INC. | exhibit10-38.htm |
EX-31.2 - CERTIFICATION - THERALINK TECHNOLOGIES, INC. | exhibit31-2.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002
The undersigned, Cameron Durrant, hereby certifies, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that
1. |
the quarterly report on Form 10-Q of PediatRx Inc. for the period ended November 30, 2011 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
2. |
the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of PediatRx Inc. |
January 17, 2012 | |
/s/ Cameron Durrant | |
Cameron Durrant | |
President, Chief Executive Officer and Director | |
(Principal Executive Officer) |